Skip to main content

Typical evanescent and atypical persistent polymorphic cutaneous rash in an adult Brazilian with Still’s disease: a case report and review of the literature

Abstract

Adult onset Still’s disease (AOSD) is a systemic auto-inflammatory condition of unknown etiology, characterized by high fever, an evanescent, salmon-pink maculopapular skin rash, arthralgia or arthritis and leukocytosis. AOSD can also present with atypical cutaneous manifestations, such as persistent pruritic coalescent papules or plaques and linear lesions that have highly distinctive pathological features and are usually associated with severe disease. Herein, we present a 31-year-old Brazilian man with both typical Still’s rash and atypical persistent polymorphic cutaneous manifestations associated with severe systemic inflammatory response syndrome. Eosinophils that are consistently lacking in the AOSD-associated skin lesions were evident in the skin biopsy of the persistent atypical cutaneous manifestations and were either drug-related or AOSD-associated.

Introduction

Adult onset Still’s disease (AOSD) is a systemic auto-inflammatory condition of unknown etiology, characterized by intermittent spiking high fever, an evanescent, salmon-pink or erythematous maculopapular skin rash, arthralgia or arthritis and leukocytosis with at least 80 % neutrophils [1]. Other common symptoms include sore throat, lymphadenopathy, hepatomegaly, and splenomegaly [2]. High serum ferritin levels, elevated ESR and high CRP levels, absent antinuclear antibody (ANA) and rheumatoid factors (RF) are the most common laboratory findings [3, 4]. We report a case of AOSD in a 31-year-old Brazilian man presenting with both typical Still’s rash and atypical non-evanescent polymorphic cutaneous manifestations.

Case presentation

A 31-year-old Brazilian male presented with high quotidian fever and night sweats, non-productive cough, lower back pain and erythematous rash for two weeks. The fever occurred almost daily and ranged from 39 to 40 °C. The rash started from both hands and was characterized by multiple erythematous confluent roundish macules and papules that coalesced to form large, irregular erythematous plaques (Fig. 1). The rash lasted for a few days and then appeared with a different morphology on the flexor surfaces of his arms as an extensive erythematous linear urticarial eruption (Fig. 2a). Subsequently the rash appeared on his upper and lower trunk as multiple intensely pruritic linear urticarial streaks (Fig. 2b). Ibuprofen has been used intermittently to alleviate back pain as well as the fever with minimal relief. He denied any contacts with sick individuals, insect or animal bites and his last trip was to Brazil 10 months ago. He has been sexually active in a monogamous relationship.

Fig. 1
figure 1

Typical evanescent rash: Multiple non-pruritic confluent erythematous macules and papules on the dorsal surface of both hands that coalesced to form irregular erythematous plaques

Fig. 2
figure 2

Atypical urticarial rash: a linear urticarial eruption on the flexor surface of arms. b Multiple intensely pruritic linear urticarial streaks on the upper and lower trunk

On admission, his temperature was 39 °C and a persistent pigmented plaque V shaped was evident on his anterior chest extending down the midline to the umbilicus (Fig. 3). Further skin examination revealed a confluent salmon-pink papular eruption on his lower back area and a persistent pigmented plaque on the upper area of his back. Besides mild splenomegaly and a tender right wrist, left second and third proximal interphalangeal joints with no signs of swelling or erythema, the rest of the physical exam was unremarkable. Laboratory profile revealed severe neutrophilic leukocytosis (30,000, normal values 4800–10,800/mcL), and a highly elevated serum ferritin levels (>10,000, normal values 17.90–464.00 ng/mL). Autoantibodies (including ANA, ANCA, RF and anti-CCP) were negative. Blood cultures excluded common viral and bacterial infections and RPR were negative. Serological tests for Hepatitis B and C, HIV, Epstein-Barr and Cytomegalovirus were negative. Borrelia burgdorferi, Bartonella henselae, Rickettsia typhi, RMSF, Typhus and Parvovirus B-19 serologies were negative as well. Parasites for malaria or Babesia microti were undetectable on peripheral blood smear. Transthoracic echocardiogram was negative for vegetations and computed tomography (CT) of the neck, chest and abdomen revealed only borderline mild splenomegaly.

Fig. 3
figure 3

Atypical persistent rash: persistent pigmented plaque V shaped on the anterior chest extending down the midline to the umbilicus

The clinical and laboratory findings were consistent with the diagnosis of AOSD according to Yamaguchi criteria [2]. He was started on 50 mg of prednisone. After 2 weeks of treatment, he returned to our hospital with very high daily spiking fever up to 39.5 °C, perfuse sweating, hypotension, elevated liver enzymes and severe leukocytosis with neutrophil predominance. No new skin lesions were noted. The patient was admitted to intensive care unit due to suspected systemic inflammatory response syndrome and was started on broad-spectrum antibiotics and intravenous fluids. Since the blood cultures were negative, antibiotics were discontinued. Anakinra 100 mg daily subcutaneously was added to 50 mg of prednisone with dramatic resolution of his febrile episodes. The patient was discharged with instructions to gradually taper prednisone.

After 1 week of treatment with Anakinra and while on 40 mg of prednisone the patient remained afebrile but new erythematous plaques appeared on lower abdominal quadrants and a skin biopsy was performed (Fig. 4). Skin biopsy showed a normal epidermis, with an inflammatory infiltrate in the dermis surrounding superficial blood vessels and adnexal structures, and the interstitium as well (Fig. 5a). The inflammatory infiltrate composed of lymphocytes, neutrophils and eosinophils (Fig. 5b). Because of the persistent cutaneous manifestations, the patient was advised to apply on the persistent eruptions of his chest and abdomen triamcinolone cream 0.5 % twice daily. After 1-month follow-up, the skin rash on the above areas almost resolved.

Fig. 4
figure 4

Atypical persistent pruritic eruption: edematous erythematous plaques on lower abdominal quadrants. Stich denotes the site of skin biopsy

Fig. 5
figure 5

a Hematoxylin and eosin (H&E) stain showing periadnexal and perivascular infiltrate of inflammatory cells surrounding blood vessels, hair follicles and the interstitium (in between the vessels and adnexal structures). Original magnification at ×100. b H&E stain showing perivascular inflammatory infiltration of lymphocytes, neutrophils and eosinophils. Original magnification at ×400

Discussion

Review of literature, via the PubMed search, using the terms adult onset Still’s disease, cutaneous manifestations and eruptions from 1985 to 2014 to retrieve data on the diversity in clinical manifestations and histopathological findings of polymorphic Still’s rash, was performed (Table 1). AOSD is a rare young adult systemic autoimmune disorder with diverse clinical manifestations and occasionally unwanted serious organ damage like acute liver failure, adult respiratory distress syndrome, disseminated intravascular coagulation, and hemophagocytic syndrome [510]. Thus, early recognition of AOSD is crucial and should be always considered in the differential diagnosis of a systemic inflammatory syndrome, particularly when extensive microbiological workup is negative.

Table 1 Clinical manifestations and histopathological findings of Still’s disease

The typical skin rash of AOSD is an evanescent salmon-pink non-pruritic or mildly pruritic maculopapular rash, with nonspecific histologic characteristics comprised of a superficial perivascular lymphocytic and scattered neutrophilic infiltrate in the upper epidermis [1113]. The lesions often develop on the extremities and over the trunk during the peak of the fever and then resolve. AOSD can also present with various atypical cutaneous manifestations and persistent pruritic eruptions (PPEs) are common [14].

PPEs are polymorphic both in morphology and distribution patterns. The more common patterns include lichenoid, linear and dermographism-like eruptions [14], persistent pruritic coalescent papules and plaques [1517] with linear pigmentation [18], dermal and mucosal hyperpigmentation [19], amyloidosis-like skin eruption [20], generalized peau d’orange appearance of the skin [21], generalized persistent erythema [22], prurigo pigmentosa-like eruption [23, 24], vesiculopustules [25], urticaria [26, 27] and fixed papular lesions [28]. The latter are characterized by atypical wheals, present for more than 24–36 h, with symmetrical distribution [29, 30]. Pruritic lesions are usually evident with the presence of linear dermographism from scratching, as was evident in our patient. The most common atypical rash manifestation in AOSD includes the persistent pruritic coalescent papules and plaques and linear lesions [31].

In addition to the typical maculopapular evanescent Still’s rash, our patient had also an atypical persistent pigmented eruption manifested with different cutaneous morphology and geographic distribution over his body. The linear urticarial streaky and dermographism-like eruptions on upper extremities and torso sequentially gave place to persistent erythematous plaques on his chest and abdomen. We believe that this type of polymorphic cutaneous eruption may be a predictor of severe systemic inflammatory disease like in our case, and could be associated with activation of macrophages and natural killer cells in addition with increased production of IL-2, interferon-γ and tumor necrosis factor (TNF)- α. High levels of IL-8 were demonstrated in Still’s rash and this cytokine is considered as the inducer of the acute phase of inflammatory cascade in AOSD [32]. We believe that the cutaneous response to Anakinra was slower than the systemic one, since the febrile episodes resolved rapidly after initiation of Anakinra whereas the skin lesions persisted. The introduction of Anakinra therapy in our patient may have slightly exacerbated the pre-existing cutaneous lesions and caused new ones at the initiation of the treatment probably due to its immune modulating effects. Anakinra has been shown to cause interstitial granulomatous drug reaction [33, 34]. The application of topical corticosteroids facilitated the resolution of the cutaneous manifestations.

The histological features of persistent eruptions include parakeratosis [35], necrotic keratinocytes in the upper epidermis and a perivascular and interstitial inflammatory infiltrate of lymphocytes and neutrophils in the upper- and mid-dermis [3639]. In urticarial lesions the histopathologic findings demonstrate an intense infiltrate of mature CD15+ neutrophils between the dermal collagen bundles. This clinicopathological entity has recently been described as neutrophilic urticarial dermatosis (NUD) [40].

Dyskeratosis and dermal mucinosis represent distinctive cutaneous lesions of AOSD [41, 42]. The presence of fibrin thrombi in the small vessel with scarce inflammatory cell infiltration, suggestive of vasculopathy [25] has also been observed in cases of AOSD. Leukocytoclastic cutaneous vasculitis [43, 44] with mixed cryoglobulinemia [44] in AOSD has been described only rare in the literature.

Eosinophils that are commonly seen in drug-induced eruption are consistently lacking in the AOSD-associated skin lesions [14]. Perez et al. described a case of AOSD-related persistent erythematous rash characterized by papules and plaques in which skin biopsy revealed perivascular infiltration of the small vessels in the dermis by eosinophils, histiocytes and lymphocytes [45]. In our case, the histopathology findings of the new persistent cutaneous eruption included the presence of several perivascular eosinophils not just in the dermis but also in the interstitium. The eosinophilic cutaneous manifestation could be either drug-related (i.e. antibiotics, Anakinra) or AOSD-associated.

Treatment of AOSD has been empirical. Non-steroidal anti-inflammatory drugs (NSAIDs), oral corticosteroids, disease modifying anti-rheumatic drugs (DMARDs), methotrexate (MTX), cyclosporine, azathioprine, sulfasalazine and minocycline have been used to treat this rare disease. Recently effective biologic agents including TNF-a, IL-1 and IL-6 antagonist have been used for steroid-resistant AOSD [46]. Laskari et al. provided evidence that Anakinra monotherapy or in combination with a DMARD, such as MTX may be the treatment of choice for patients with refractory Still’s disease [47]. MTX is recommended in patients with polyarthritis and allows for steroid dose sparing in AOSD [48]. Our patient did not respond to corticosteroid treatment, but showed dramatic response to initiation of Anakinra treatment.

In summary, AOSD can manifest with atypical skin lesions that have highly distinctive but non-pathognomonic pathological features and are usually associated with severe disease. Still’s rash can mimic various disorders with maculopapular, urticarial, linear and lichenoid manifestations and skin biopsy of those atypical cutaneous lesions is strongly recommended before or during the treatment course of AOSD because it allows rheumatologists and pathologists to recognize those specific distinctive histopathological characteristics and put the correct diagnosis.

References

  1. Fautrel B (2008) Adult-onset Still disease. Best Pract Res Clin Rheumatol 22(5):773–792

    Article  PubMed  Google Scholar 

  2. Yamagushi M, Ohta A, Tsunematsu T et al (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430

    Google Scholar 

  3. Appenzeller S, Castro GR, Costallat LT et al (2005) Adult onset Still disease in southeast Brazil. J Clin Rheumatol 11:76–80

    Article  PubMed  Google Scholar 

  4. Jaime MAI, Baptista R, Azevedo MNL et al (1998) Adult onset Still’s disease: study on 25 cases. Rev Bras Rheumatol 38:285–290

    Google Scholar 

  5. Crispin JC, Martinez-Banos D, Alcocer-Varela J (2005) Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore) 84:331–337

    Article  Google Scholar 

  6. Bywaters EG (1971) Still’s disease in the adult. Ann Rheum Dis 30(2):121–133

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Dino O, Provenzano G, Giannuoli G et al (1996) Fulminant hepatic failure in adult onset Still’s disease. J Rheumatol 23(4):784–785

    CAS  PubMed  Google Scholar 

  8. Hirohata S, Kamoshita H, Taketani T et al (1986) Adult Still’s disease complicated with adult respiratory distress. Arch Intern Med 146(12):2409–2410

    Article  CAS  PubMed  Google Scholar 

  9. Vallianou NG, Kouvidou C, Naxaki A et al (2014) Acalculous cholecystitis with multiple organ failure and disseminated intravascular coagulation in a patient with adult onset Still’s disease. Ann Gastroenterol 27(3):289–290

    PubMed Central  PubMed  Google Scholar 

  10. Bae CB, Jung JY, Kim HA et al (2015) Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 94(4):e451

    Article  PubMed Central  PubMed  Google Scholar 

  11. Lee JY, Yang C, Hsu MM (2005) Histopathology of persistent papules and plaques in adult-onset Still’s disease. J Am Acad Dermpath 52:1003–1008

    Article  Google Scholar 

  12. Wouters JM, van Rijswijk MH, van de Putte LB (1985) Adult onset Still’s disease in the elderly: a report of two cases. J Rheumatol 12(4):791–793

    CAS  PubMed  Google Scholar 

  13. Koga T, Tokunaga N, Ichikawa Y et al (1992) A 72-year-old female with adult Still’s disease. Intern Med 31(12):1356–1358

    Article  CAS  PubMed  Google Scholar 

  14. Lee JY, Hsu CK, Liu MF et al (2012) Evanescent and persistent pruritic eruptions of adult-onset still disease: a clinical and pathologic study of 36 patients. Semin Arthritis Rheum 42(3):317–326

    Article  PubMed  Google Scholar 

  15. Kaur S, Bambery P, Dahr S (1994) Persistent dermal plaque lesions in adult onset Still’s disease. Dermatology 188:241–242

    Article  CAS  PubMed  Google Scholar 

  16. Yoshifuku A, Kawai K, Kanekura T (2014) Adult-onset Still disease with peculiar persistent plaques and papules. Clin Exp Dermatol 39(4):503–505

    Article  CAS  PubMed  Google Scholar 

  17. Thien Huong NT, Pitche P, Minh Hoa T et al (2005) Persistent pigmented plaques in adult-onset Still’s disease. Ann Dermatol Venereol. 132(8–9 Pt 1):693–696 (French )

  18. Suzuki K, Kimura Y, Aoki M et al (2001) Persistent plaques and linear pigmentation in adult-onset Still’s disease. Dermatology 202(4):333–335 (Review )

  19. Sarkar RN, Bhattacharya R, Bhattacharyya K et al (2014) Adult onset Still’s disease with persistent skin lesions complicated by secondary hemophagocytic lymphohistiocytosis. Int J Rheum Dis 17(1):118–121

    Article  PubMed  Google Scholar 

  20. Yammamoto M, Sueki H, Fujisawa R et al (1999) A case of adult Still’s disease with atypical rash. Rinsho Derma 41:365–368

    Google Scholar 

  21. Phillips WG, Weller R, Handfield-Johnes SE et al (1994) Adult Still’s disease. Br J Dermatol 130:511–513

    Article  CAS  PubMed  Google Scholar 

  22. Fujii K, Kobishi K, Kanno Y et al (2003) Persistent generalized erythema in adult-onset Still’s disease. Int J Dermatol 42:824–825

    Article  PubMed  Google Scholar 

  23. Tomaru K, Nagai Y, Ohyama N et al (2006) Adult-onset Still’s disease with prurigo pigmentosa-like skin eruption. J Dermatol 33(1):55–58

    Article  PubMed  Google Scholar 

  24. Cho YT, Liao YH (2014) Prurigo pigmentosa-like persistent papules and plaques in a patient with adult-onset Still’s disease. Acta Derm Venereol 94(1):102–103

    Article  PubMed  Google Scholar 

  25. Lee JB, Kim JW, Lee SS et al (2002) Adult-onset Still’s disease with vesiculopustules on the hands and feet. J Korean Med Sci 17(6):852–855

    Article  PubMed Central  PubMed  Google Scholar 

  26. Criado PR, de Carvalho JF, Ayabe LA et al (2012) Urticaria and dermographism in patients with adult-onset Still’s disease. Rheumatol Int 32(8):2551–2555

    Article  PubMed  Google Scholar 

  27. Tay YK, Paz RS, Ng SK et al (1996) A case of adult onset Still’s disease presenting with fever and a rash. Ann Acad Med Singap 25(2):296–299

    CAS  PubMed  Google Scholar 

  28. Soy M (2004) A case of adult-onset Still’s disease presenting with angioedema. Clin Rheumatol 23:92

    Article  PubMed  Google Scholar 

  29. Peroni A, Colato C, Zanoni G et al (2010) Urticarial lesions: if not urticarial, what else? The differential diagnosis of urticaria: part II. Systemic diseases. J Am Acad Dermatol 62:557–570

    Article  PubMed  Google Scholar 

  30. Setterfield JE, Hughes GRV (1998) Kobza Black A. Urticaria as a presentation of adult Still’s disease. Br J Dermatol 138:904–927

    Article  Google Scholar 

  31. Criado RF, Criado PR, Vasconcellos C et al (2006) Urticaria as a cutaneous sign of adult-onset Still’s disease. J Cutan Med Surg 10(2):99–103

  32. Chen DY, Lan JL, Lin FJ et al (2004) Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease. J Rheumatol 31(11):2189–2198

    CAS  PubMed  Google Scholar 

  33. Regula CG, Hennessy J, Clarke LE et al (2008) Interstitial granulomatous drug reaction to anakinra. J Am Acad Dermatol 59:S25–S27

    Article  PubMed  Google Scholar 

  34. Michailidou D, Voulgarelis M, Pikazis D (2014) Exacerbation of interstitial granulomatous dermatitis with arthritis by anakinra in a patient with diffuse large B-cell lymphoma. Clin Exp Rheumatol 32(2):259–261

  35. Lübbe J, Hofer M, Chavaz P et al (1999) Adult-onset Still’s disease with persistent plaques. Br J Dermatol 141(4):710–713

    Article  PubMed  Google Scholar 

  36. Nagai Y, Hasegawa M, Okada E et al (2012) Clinical follow-up study of adult-onset Still’s disease. J Dermatol 39(11):898–901

    Article  PubMed  Google Scholar 

  37. Yang CC, Lee JY, Liu MF et al (2006) Adult-onset Still’s disease with persistent skin eruption and fatal respiratory failure in a Taiwanese woman. Eur J Dermatol 16(5):593–594

  38. Salaffi F, Filosa G, Bugatti L et al (2000) Urticaria as a presenting manifestation of adult-onset Still’s disease. Clin Rheumatol 19(5):389–391

    Article  CAS  PubMed  Google Scholar 

  39. Said NH, Wong SN, Tan WH (2013) A case of adult-onset Still’s disease presenting with urticated plaques and acute myopericarditis. Indian J Dermatol 58(5):405

    Article  PubMed Central  PubMed  Google Scholar 

  40. Cozzi A, Papagrigoraki A, Biasi D et al (2014) Cutaneous manifestations of adult-onset Still’s disease: a case report and review of literature. Clin Rheumatol. doi:10.1007/s10067-014-2614-2

  41. Wolgamot G, Yoo J, Hurst S et al (2007) Unique histopathologic findings in a patient with adult-onset Still disease. Am J Dermatopathol 29(2):194–196

    Article  PubMed  Google Scholar 

  42. Fortna RR, Gudjonsson JE, Seidel G et al (2010) Persistent pruritic papules and plaques: a characteristic histopathologic presentation seen in a subset of patients with adult-onset and juvenile Still’s disease. J Cutan Pathol 37(9):932–937

    Article  PubMed  Google Scholar 

  43. Yanai H, Furutani N, Yoshida H et al (2009) Myositis, vasculitis, hepatic dysfunction in adult-onset Still’s disease. Case Rep Med. 2009:504897

    PubMed Central  PubMed  Google Scholar 

  44. Elezoglou AV, Giamarelos-Bourboulis E, Katsilambros N et al (2003) Cutaneous vasculitis associated with mixed cryoglobulinemia in adult Still’s disease. Clin Exp Rheumatol 21(3):405–406

  45. Perez C, Montes M, Gallego M et al (2001) Atypical presentation of adult Still’s disease with generalized rash and hyperferritinaemia. Br J Dermatol 145(1):187–188

    Article  CAS  PubMed  Google Scholar 

  46. Franchini S, Dagna L, Salvo F et al (2010) Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease. Arthritis Rheum 62(8):2530–2535

    Article  CAS  PubMed  Google Scholar 

  47. Laskari K, Tzioufas AG, Moutsopoulos HM (2011) Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still’s disease: a case-series study. Arthritis Res Ther 13(3):R91

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Fautrel B, Borget C, Rozenberg S et al (1999) Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease. J Rheumatol 26(2):373–378

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Emeritus Professor H.M. Moutsopoulos, MD (Department of Pathophysiology, School of Medicine, National and Kapodistrian University of Athens) for his instructive comments and suggestions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Despina Michailidou.

Ethics declarations

Conflict of interest

There is no conflict of interest. All authors participated in the preparation of this manuscript.

Human and animal rights

For this case report formal consent is not required.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Michailidou, D., Shin, J., Forde, I. et al. Typical evanescent and atypical persistent polymorphic cutaneous rash in an adult Brazilian with Still’s disease: a case report and review of the literature. Autoimmun Highlights 6, 39–46 (2015). https://doi.org/10.1007/s13317-015-0071-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13317-015-0071-9

Keywords

  • AOSD
  • Systemic inflammatory response syndrome
  • Eosinophils
  • Atypical cutaneous manifestations